Hao Pan

Hao Pan is a notable inventor based in Hangzhou, China, recognized for his contributions to the field of biotechnology. He has been instrumental in developing innovative solutions aimed at addressing critical health issues. With a total of three patents to his name, his work focuses on the development of antibodies that target specific human receptors.

Latest Patents

Hao Pan's latest patents include a significant invention titled "Human endothelin receptor antibody and use thereof." This invention discloses an antibody that specifically binds to a human endothelin receptor, effectively inhibiting its functions. The patent details the preparation, cloning, expression, and characterization of the antibody. This innovative approach has potential applications in treating pulmonary arterial hypertension and reproductive organ cancers in humans.

Career Highlights

Throughout his career, Hao Pan has worked with various companies, including Gmax Biopharm LLC and Zhejiang Quzhou Juxin Fluorine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and biotechnology.

Collaborations

Hao Pan has collaborated with several professionals in his field, including Cheng Zhang and Hua Zhang. These collaborations have further enhanced his research and development efforts.

Conclusion

Hao Pan's work in developing human endothelin receptor antibodies showcases his commitment to advancing medical science. His innovative patents hold promise for treating serious health conditions, reflecting his significant impact on the biotechnology industry.

Profile summary based on public USPTO records.